Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy

Molecular Pharmaceutics

Volumn 8, Issue 4, 2011, Pages 1401-1407

  Aryal, Santosh ^a,b   Hu, Che Ming Jack ^a,c   Zhang, Liangfang ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

codelivery; dual drug delivery; hybrid nanoparticles; polymer drug conjugate; ratiometric drug loading

Indexed keywords

CAMPTOTHECIN; DOXORUBICIN; HYDROXYL GROUP; LIPID; NANOPARTICLE; POLYLACTIDE;

COMBINATION CHEMOTHERAPY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; INTERNALIZATION; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; REVIEW; RING OPENING METATHESIS POLYMERIZATION; SURFACE CHARGE;

CAMPTOTHECIN; DOXORUBICIN; DRUG CARRIERS; NANOPARTICLES; POLYESTERS; POLYMERS;

EID: 79961050017     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200243k     Document Type: Review

References (31)

1. Yuan, F.; Dellian, M.; Fukumura, D.; Leunig, M.; Berk, D. A.; Torchilin, V. P.; Jain, R. K. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size Cancer Res. 1995, 55, 3752-3756
2. Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discovery 2005, 4, 145-160 (Pubitemid 40282557)
3. Hobbs, S. K.; Monsky, W. L.; Yuan, F.; Roberts, W. G.; Griffith, L.; Torchilin, V. P.; Jain, R. K. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 4607-4612 (Pubitemid 28207960)
4. Couvreur, P.; Vauthier, C. Nanotechnology: intelligent design to treat complex disease Pharm. Res. 2006, 23, 1417-1450 (Pubitemid 43993807)
5. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 1986, 46, 6387-6392 (Pubitemid 17221789)
6. Wang, A. Z.; Gu, F.; Zhang, L.; Chan, J. M.; Radovic-Moreno, A.; Shaikh, M. R.; Farokhzad, O. C. Biofunctionalized targeted nanoparticles for therapeutic applications Expert Opin. Biol. Ther. 2008, 8, 1063-1070
7. Bonadonna, G.; Zucali, R.; Monfardini, S.; De Lena, M.; Uslenghi, C. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP Cancer 1975, 36, 252-259
8. Scheithauer, W.; Rosen, H.; Kornek, G. V.; Sebesta, C.; Depisch, D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer BMJ [Br. Med. J.] 1993, 306, 752-755 (Pubitemid 23080053)
9. Gottesman, M. M. Mechanisms of cancer drug resistance Annu. Rev. Med. 2002, 53, 615-627 (Pubitemid 34177898)
10. Bradshaw, D. M.; Arceci, R. J. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance J. Clin. Oncol. 1998, 16, 3674-3690 (Pubitemid 28506783)
11. Tanabe, M.; Ito, Y.; Tokudome, N.; Sugihara, T.; Miura, H.; Takahashi, S.; Seto, Y.; Iwase, T.; Hatake, K. Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes Breast Cancer 2009, 16, 301-306
12. Muggia, F. Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer Gynecol. Oncol. 2009, 112, 275-281
13. Berhoune, M.; Banu, E.; Scotte, F.; Prognon, P.; Oudard, S.; Bonan, B. Therapeutic strategy for treatment of metastatic non-small cell lung cancer Ann. Pharmacother. 2008, 42, 1640-1652
14. Hu, C.-M. J.; Aryal, S.; Zhang, L. Nanoparticle-assisted combination therapy for effective cancer treatment Ther. Delivery 2010, 1, 321-334
15. Song, X. R.; Cai, Z.; Zheng, Y.; He, G.; Cui, F. Y.; Gong, D. Q.; Hou, S. X.; Xiong, S. J.; Lei, X. J.; Wei, Y. Q. Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles Eur. J. Pharm. Sci. 2009, 37, 300-305
16. Soma, C. E.; Dubernet, C.; Bentolila, D.; Benita, S.; Couvreur, P. Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles Biomaterials 2000, 21, 1-7
17. Ahmed, F.; Pakunlu, R. I.; Brannan, A.; Bates, F.; Minko, T.; Discher, D. E. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug J. Controlled Release 2006, 116, 150-158 (Pubitemid 44868999)
18. Zhang, L.; Radovic-Moreno, A. F.; Alexis, F.; Gu, F. X.; Basto, P. A.; Bagalkot, V.; Jon, S.; Langer, R. S.; Farokhzad, O. C. Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates ChemMedChem 2007, 2, 1268-1271
19. Lammers, T.; Subr, V.; Ulbrich, K.; Peschke, P.; Huber, P. E.; Hennink, W. E.; Storm, G. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers Biomaterials 2009, 30, 3466-3475
20. Bae, Y.; Diezi, T. A.; Zhao, A.; Kwon, G. S. Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents J. Controlled Release 2007, 122, 324-330 (Pubitemid 47404677)
21. Kolishetti, N.; Dhar, S.; Valencia, P. M.; Lin, L. Q.; Karnik, R.; Lippard, S. J.; Langer, R.; Farokhzad, O. C. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 17939-17944
22. Sengupta, S.; Eavarone, D.; Capila, I.; Zhao, G.; Watson, N.; Kiziltepe, T.; Sasisekharan, R. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system Nature 2005, 436, 568-572 (Pubitemid 41112931)
23. Aryal, S.; Hu, C. M.; Zhang, L. Combinatorial drug conjugation enables nanoparticle dual-drug delivery Small 2010, 6, 1442-1448
24. Tong, R.; Cheng, J. Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates Bioconjugate Chem. 2010, 21, 111-121
25. Tong, R.; Cheng, J. Paclitaxel-initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles Angew. Chem., Int. Ed. 2008, 47, 4830-4834
26. Tong, R.; Cheng, J. Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles J. Am. Chem. Soc. 2009, 131, 4744-4754
27. Chamberlain, B. M.; Cheng, M.; Moore, D. R.; Ovitt, T. M.; Lobkovsky, E. B.; Coates, G. W. Polymerization of lactide with zinc and magnesium beta-diiminate complexes: stereocontrol and mechanism J. Am. Chem. Soc. 2001, 123, 3229-3238 (Pubitemid 32884612)
28. Chan, J. M.; Zhang, L.; Yuet, K. P.; Liao, G.; Rhee, J. W.; Langer, R.; Farokhzad, O. C. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery Biomaterials 2009, 30, 1627-1634
29. Hu, C. M.; Kaushal, S.; Tran Cao, H. S.; Aryal, S.; Sartor, M.; Esener, S.; Bouvet, M.; Zhang, L. Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells Mol. Pharmaceutics 2010, 7, 914-920
30. Masquelier, M.; Baurain, R.; Trouet, A. Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestion J. Med. Chem. 1980, 23, 1166-1170 (Pubitemid 11163825)
31. Dubowchik, G. M.; Walker, M. A. Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs Pharmacol. Ther. 1999, 83, 67-123 (Pubitemid 29438597)